Monitoring the killer instinct: Studying NK cell ADCC responses in real time
In this webinar, Dr. Nick Maskalenko, Postdoc Associate at Fox Chase Cancer Center, will discuss the role of natural killer (NK) cells in cancer immunotherapy and how polymorphisms of the Fc gamma receptor CD16 factor into antibody dependent cellular cytotoxicity (ADCC) responses against tumor cells.
Furthermore, he will explore the unique features and advantages of xCELLigence Real-Time Cell Analysis (RTCA) technology in cancer immunotherapy, the important value of monitoring real-time cell killing, and how the kinetics of cell killing can provide valuable insight into effector processes that can be exploited to improve NK cell cytotoxicity.
Key learning objectives
- Learn about the role of NK cells in cancer immunotherapy
- Explore how xCELLigence RTCA can be used to monitor kinetics of cell killing
- Understand how variations in the CD16 receptor affect ADCC
Who should attend?
- Researchers focused on cancer immunotherapy
- Scientists who are looking to implement real-time cell analysis into workflows
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.